Literature DB >> 21901406

[Acetylsalicylic acid for primary cardiovascular prevention dependent on the role of the ankle brachial index].

K Schrör1, S Nitschmann.   

Abstract

Entities:  

Year:  2011        PMID： 21901406     DOI： 10.1007/s00108-011-2941-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  5 in total

1.  Association of low ankle brachial index with high mortality in primary care.

Authors:  Curt Diehm; Stefan Lange; Harald Darius; David Pittrow; Berndt von Stritzky; Gerhart Tepohl; Roman L Haberl; Jens Rainer Allenberg; Burkhard Dasch; Hans Joachim Trampisch
Journal:  Eur Heart J       Date:  2006-06-16       Impact factor: 29.983

2.  Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

Authors:  G Davì; P Gresele; F Violi; S Basili; M Catalano; C Giammarresi; R Volpato; G G Nenci; G Ciabattoni; C Patrono
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

Review 3.  Functional testing methods for the antiplatelet effects of aspirin.

Authors:  Karsten Schrör; Kurt Huber; Thomas Hohlfeld
Journal:  Biomark Med       Date:  2011-02       Impact factor: 2.851

Review 4.  Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review.

Authors:  Anand V Doobay; Sonia S Anand
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-05-05       Impact factor: 8.311

5.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.